SOLUTION OF THE CONFORMATION AND ALIGNMENT TENSORS FOR THE BINDING OFTRIMETHOPRIM AND ITS ANALOGS TO DIHYDROFOLATE-REDUCTASE - 3D-QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDY USING MOLECULAR SHAPE-ANALYSIS, 3-WAY PARTIAL LEAST-SQUARES REGRESSION, AND 3-WAY FACTOR-ANALYSIS
Wj. Dunn et al., SOLUTION OF THE CONFORMATION AND ALIGNMENT TENSORS FOR THE BINDING OFTRIMETHOPRIM AND ITS ANALOGS TO DIHYDROFOLATE-REDUCTASE - 3D-QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDY USING MOLECULAR SHAPE-ANALYSIS, 3-WAY PARTIAL LEAST-SQUARES REGRESSION, AND 3-WAY FACTOR-ANALYSIS, Journal of medicinal chemistry, 39(24), 1996, pp. 4825-4832
Molecular recognition is the basis of rational drug design, and for th
is reason it has been extensively studied. However, the process by whi
ch a ligand recognizes and binds to its receptor is complex and not we
ll understood. For the case in which the geometries (conformation and
alignment) of the ligand and receptor are known from X-ray crystal str
ucture data, the problem is simplified. The receptor-bound conformatio
n and alignment of the ligand is assumed, and those of additional liga
nds are inferred. For the general case in which the geometries of the
ligand(s) and receptor are unknown, no general treatment or solution i
s available and receptor-ligand geometries must be obtained indirectly
from structure-activity studies or synthesis and evaluation of rigid
analogs. A general treatment for solving for the receptor-bound geomet
ry of a series of ligands is presented here. Using molecular shape ana
lysis, for ligand description, tensor analysis of N-way arrays by part
ial least-squares (PLS) regression, and 3-way factor analysis, the rec
eptor-bound geometries of trimethoprim and a series of trimethoprim-li
ke dihydrofolate reductase inhibitors are correctly predicted.